Table 2

Final pathology results

Histologic subtype (%)
 Squamous794 (68.7)
 Adenocarcinoma323 (27.9)
 Adenosquamous39 (3.4)
Tumor measurements, mm (SD)
 Lateral extension18.75 (11.7)
 Anterior-posterior extension14.86 (10.5)
 Depth of invasion9.67 (7.8)
 Uninvolved stroma7.65 (5.8)
Tumor maximum diameter by pathology (%)
 <2 cm656 (56.7)
 ≥2 cm500 (43.3)
Grade (%)
 Well differentiated192 (16.6)
 Moderately differentiated519 (44.9)
 Poorly differentiated336 (29.1)
 Not reported109 (9.4)
Lymphovascular space invasion (%)
 No588 (50.9)
 Yes437 (37.8)
 Not reported131 (11.3)
Depth of Invasion (%)
 Superficial (invades <1/3 of the stroma)269 (23.3)
 Intermediate (invades between 1/3 and 2/3 of the stroma)307 (26.6)
 Deep (invades >2/3 of the stroma)278 (24.0)
 Not reported302 (26.1)
Parametrial invasion (%)
 No1090 (94.3)
 Yes33 (2.9)
 Not reported33 (2.9)
Vaginal infiltration in the specimen (%)
 No1085 (93.9)
 Yes30 (2.6)
 Not reported41 (3.5)
Margin status (%)
 Free margins1070 (92.6)
 Free but close margins (<2 mm)63 (5.4)
 Positive margins (invasive disease)16 (1.4)
 Positive margins (pre-invasive disease)7 (0.6)
Number of lymph nodes (SD)23.51 (12.4)
Nodal status (%)
 Negative1013 (87.6)
 Positive143 (12.4)
FIGO 2018 stage (%)
 IB1510 (44.1)
 IB2480 (41.5)
 IIA19 (0.8)
 IIB14 (1.2)
 IIIC1140 (12.1)
 IIIC23 (0.3)